An integrative multi-platform analysis for discovering biomarkers of osteosarcoma
Open Access
- 16 May 2009
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 150
Abstract
SELDI-TOF-MS (Surface Enhanced Laser Desorption/Ionization-Time of Flight-Mass Spectrometry) has become an attractive approach for cancer biomarker discovery due to its ability to resolve low mass proteins and high-throughput capability. However, the analytes from mass spectrometry are described only by their mass-to-charge ratio (m/z) values without further identification and annotation. To discover potential biomarkers for early diagnosis of osteosarcoma, we designed an integrative workflow combining data sets from both SELDI-TOF-MS and gene microarray analysis.Keywords
This publication has 21 references indexed in Scilit:
- The Universal Protein Resource (UniProt) 2009Nucleic Acids Research, 2009
- Applications of SELDI‐MS technology in oncologyJournal of Cellular and Molecular Medicine, 2008
- 2‐D DIGE and MALDI‐TOF‐MS analysis of the serum proteome in human osteosarcomaProteomics – Clinical Applications, 2007
- Link test—A statistical method for finding prostate cancer biomarkersComputational Biology and Chemistry, 2006
- Discovery of Urinary BiomarkersMolecular & Cellular Proteomics, 2006
- Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondromaProteomics, 2006
- Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experimentsBioinformatics, 2004
- The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003Nucleic Acids Research, 2003
- Cytochrome c Release upon Fas Receptor Activation Depends on Translocation of Full-length Bid and the Induction of the Mitochondrial Permeability TransitionJournal of Biological Chemistry, 2002
- Pathology of OsteosarcomaClinical Orthopaedics and Related Research, 1975